All articles tagged with #gaba labs
David Nutt, a neuropsychopharmacology expert, is developing a molecule called Alcarelle through GABA Labs to mimic the relaxing effects of alcohol without its downsides, aiming to revolutionize the nonalcoholic beverage market amid changing social attitudes and health concerns. The company is close to market with plans for testing and licensing, while existing nonalcoholic drinks are gaining popularity, though they currently lack the potency of alcohol.
London-based company GABA Labs is developing a synthetic alcohol called Alcarelle that aims to deliver the pleasurable effects of alcohol without the negative side effects. Alcarelle targets only GABA receptors in the brain, allowing for the release of dopamine and serotonin while avoiding undesirable effects. The tasteless synthetic alcohol can be added to nonalcoholic drinks or mixed with real alcohol. GABA Labs plans to complete U.S. food-safety testing by mid-2026 and launch in European markets. The development of drugs to reduce alcohol cravings and speed up hangover recovery is also underway. The decline in alcohol consumption among Americans, along with the potential adverse health effects of drinking, has fueled interest in alternative options.